Home > CVS Analysis

Is CVS Health Corporation (CVS) Undervalued?

Based on the current stock price of $79.61 and a P/E ratio of 209.50,CVS Health Corporation has a PEG ratio of 9.20.

The Short Answer:

Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 9.20, CVS appears to be potentially overvalued relative to its growth rate of 22.78%.

Valuation Status
Overvalued

Based on a PEG ratio of 8.02 (adjusted for dividends).

01.02.0+
P/E Ratio
209.50
Growth Rate
22.78%
Stock Price
$79.61
Market Cap
101059518464

Compare CVS vs Competitors

Use the calculator below to see how CVS stacks up against other stocks in the same industry.

Analyze Any Stock

Get instant P/E, PEG, and PEGY ratios with real-time data

💡 Try popular stocks: AAPL, MSFT, GOOGL, TSLA, AMZN, NVDA, META

How we analyzed CVS

We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 209.50and dividing it by the annual growth rate of 22.78%.

PEG = 209.50 (P/E) ÷ 22.78 (Growth) = 9.20

Frequently Asked Questions about CVS

What is the current PEG Ratio for CVS Health Corporation (CVS)?+

The current PEG Ratio for CVS Health Corporation is 9.20. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.

Is CVS stock undervalued right now?+

Based on the PEG ratio of 9.20, CVS Health Corporation appears to be potentially overvalued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.

What is the PEGY Ratio for CVS?+

The PEGY ratio for CVS Health Corporation is 8.02. This metric accounts for dividend yield (3.34%), providing a more complete valuation picture.